SuperGen supergen.com


Public list: Pharma Startups (4743) Cancer Therapeutics (1148)

SuperGen is a pharmaceutical company whose mission is to prolong, improve the quality of and ultimately, save the lives of those people afflicted with life-threatening diseases, especially cancer. The company possesses a broad portfolio of proprietary cancer therapies that target a variety of solid tumors, hematological malignancies and blood disorders, offering renewed hope to patients who suffer from these illnesses.

SuperGen is a pharmaceutical company whose mission is to prolong, improve the quality of and ultimately, save the lives of those people afflicted with life-threatening diseases, especially cancer. The company possesses a broad portfolio of proprietar...Show all

Company (Alive / Active)

Phone: 925-560-0100

Fax:

4140 Dublin Boulevard
Suite 200
Dublin, 94568
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
SuperGen $39.2M Mar 19, 2004
See all 20 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related SuperGen Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 24 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 20 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Axl kinase inhibitors Apr 11, 2008 Aug 16, 2011 Patent
Quinoline derivatives for modulating dna methylation Apr 10, 2009 May 10, 2011 Patent
Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same Mar 03, 2008 Oct 26, 2010 Patent
Oligonucleotide analogues incorporating 5-aza-cytosine therein Sep 29, 2005 Apr 20, 2010 Patent